384 related articles for article (PubMed ID: 16037278)
1. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
[TBL] [Abstract][Full Text] [Related]
2. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
Ramasamy R; Yan SF; Schmidt AM
Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
Yan SF; Ramasamy R; Schmidt AM
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end product receptor-mediated cellular dysfunction.
Bierhaus A; Humpert PM; Stern DM; Arnold B; Nawroth PP
Ann N Y Acad Sci; 2005 Jun; 1043():676-80. PubMed ID: 16037292
[TBL] [Abstract][Full Text] [Related]
5. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
Yan SF; D'Agati V; Schmidt AM; Ramasamy R
Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
[TBL] [Abstract][Full Text] [Related]
6. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.
Schmidt AM; Hofmann M; Taguchi A; Yan SD; Stern DM
Semin Thromb Hemost; 2000; 26(5):485-93. PubMed ID: 11129404
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
[TBL] [Abstract][Full Text] [Related]
8. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
Yan SF; Ramasamy R; Naka Y; Schmidt AM
Circ Res; 2003 Dec; 93(12):1159-69. PubMed ID: 14670831
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
11. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
Nishizawa Y; Koyama H
J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
[TBL] [Abstract][Full Text] [Related]
12. RAGE, vascular tone and vascular disease.
Farmer DG; Kennedy S
Pharmacol Ther; 2009 Nov; 124(2):185-94. PubMed ID: 19616578
[TBL] [Abstract][Full Text] [Related]
13. RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair.
Rong LL; Gooch C; Szabolcs M; Herold KC; Lalla E; Hays AP; Yan SF; Yan SS; Schmidt AM
Restor Neurol Neurosci; 2005; 23(5-6):355-65. PubMed ID: 16477098
[TBL] [Abstract][Full Text] [Related]
14. RAGE axis: Animal models and novel insights into the vascular complications of diabetes.
Naka Y; Bucciarelli LG; Wendt T; Lee LK; Rong LL; Ramasamy R; Yan SF; Schmidt AM
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1342-9. PubMed ID: 15155381
[TBL] [Abstract][Full Text] [Related]
15. RAGE biology, atherosclerosis and diabetes.
Barlovic DP; Soro-Paavonen A; Jandeleit-Dahm KA
Clin Sci (Lond); 2011 Jul; 121(2):43-55. PubMed ID: 21457145
[TBL] [Abstract][Full Text] [Related]
16. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury.
Zhou Z; Wang K; Penn MS; Marso SP; Lauer MA; Forudi F; Zhou X; Qu W; Lu Y; Stern DM; Schmidt AM; Lincoff AM; Topol EJ
Circulation; 2003 May; 107(17):2238-43. PubMed ID: 12719284
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
Yamagishi S
Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
[TBL] [Abstract][Full Text] [Related]
18. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
[TBL] [Abstract][Full Text] [Related]
19. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
[TBL] [Abstract][Full Text] [Related]
20. RAGE in inflammation: a new therapeutic target?
Bierhaus A; Stern DM; Nawroth PP
Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
